479 related articles for article (PubMed ID: 27544590)
1. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
[TBL] [Abstract][Full Text] [Related]
2. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein JA; Jambal P; Peoples K; Lucky AW; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Hook KP; Levin LE; Morel KD; Paller AS; McCuaig CC; Powell J; Eichenfield LF; Price H; Levy ML; Schachner LA; Browning JC; Bayliss S; Jahnke M; Shwayder T; Glick SA; Bruckner AL
JAMA Dermatol; 2019 Feb; 155(2):196-203. PubMed ID: 30586139
[TBL] [Abstract][Full Text] [Related]
4. Unravelling drivers of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
Santucci C; Alexandru M; Chen X; Mellerio JE; Karagiannis SN; Jacków-Malinowska J
Hum Immunol; 2024 May; 85(3):110805. PubMed ID: 38703415
[TBL] [Abstract][Full Text] [Related]
5. Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a retrospective study.
Filoni A; Cicco G; Lospalluti L; Maglietta A; Foti C; Annichiarico G; Resta L; Bonamonte D
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1707-1714. PubMed ID: 31692111
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
[TBL] [Abstract][Full Text] [Related]
7. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
Fine JD; Johnson LB; Weiner M; Li KP; Suchindran C
J Am Acad Dermatol; 2009 Feb; 60(2):203-11. PubMed ID: 19026465
[TBL] [Abstract][Full Text] [Related]
8. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature.
Yuen WY; Jonkman MF
J Am Acad Dermatol; 2011 Oct; 65(4):780-789. PubMed ID: 21624701
[TBL] [Abstract][Full Text] [Related]
9. Immunofluorescence antigen mapping for hereditary epidermolysis bullosa.
Rao R; Mellerio J; Bhogal BS; Groves R
Indian J Dermatol Venereol Leprol; 2012; 78(6):692-7. PubMed ID: 23075637
[TBL] [Abstract][Full Text] [Related]
10. [Hereditary epidermolysis bullosa: French national guidelines (PNDS) for diagnosis and treatment].
Chiaverini C; Bourrat E; Mazereeuw-Hautier J; Hadj-Rabia S; Bodemer C; Lacour JP
Ann Dermatol Venereol; 2017 Jan; 144(1):6-35. PubMed ID: 27931749
[TBL] [Abstract][Full Text] [Related]
11. Treatment of skin cancers in epidermolysis bullosa.
Venugopal SS; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):283-7, ix-x. PubMed ID: 20447493
[TBL] [Abstract][Full Text] [Related]
12. Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.
Condorelli AG; Dellambra E; Logli E; Zambruno G; Castiglia D
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739489
[TBL] [Abstract][Full Text] [Related]
13. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
[TBL] [Abstract][Full Text] [Related]
14. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
[TBL] [Abstract][Full Text] [Related]
15. Age and etiology of childhood epidermolysis bullosa mortality.
Hon KL; Li JJ; Cheng BL; Luk DC; Murrell DF; Choi PC; Leung AK
J Dermatolog Treat; 2015 Apr; 26(2):178-82. PubMed ID: 24724596
[TBL] [Abstract][Full Text] [Related]
16. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas.
Föll MC; Fahrner M; Gretzmeier C; Thoma K; Biniossek ML; Kiritsi D; Meiss F; Schilling O; Nyström A; Kern JS
Matrix Biol; 2018 Mar; 66():1-21. PubMed ID: 29158163
[TBL] [Abstract][Full Text] [Related]
17. Assessment of mobility, activities and pain in different subtypes of epidermolysis bullosa.
Fine JD; Johnson LB; Weiner M; Suchindran C
Clin Exp Dermatol; 2004 Mar; 29(2):122-7. PubMed ID: 14987264
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing epidermolysis bullosa type and subtype in infancy using immunofluorescence microscopy: the Stanford experience.
Berk DR; Jazayeri L; Marinkovich MP; Sundram UN; Bruckner AL
Pediatr Dermatol; 2013; 30(2):226-33. PubMed ID: 23461686
[TBL] [Abstract][Full Text] [Related]
19. Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Welponer T; Weber DD; Trattner L; Tockner B; Aminzadeh-Gohari S; Leb-Reichl V; Kaufmann A; Zauner R; Wimmer M; Wally V; Felder TK; Strunk D; Koller U; Bauer JW; Kofler B; Guttmann-Gruber C; Piñon Hofbauer J
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):112-123. PubMed ID: 37669776
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Inherited Epidermolysis Bullosa in Resource-Limited Settings: Immunohistochemistry Revisited.
Yenamandra VK; Bhari N; Ray SB; Sreenivas V; Dinda AK; Scaria V; Sharma VK; Sethuraman G
Dermatology; 2017; 233(4):326-332. PubMed ID: 29069641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]